- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 14.82M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 10.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 3.05M sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.36M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$1.85M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $3.09M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.29M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $3.9M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $4.12M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.62M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.7M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.83M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.94M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $6.57M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $8.85M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $6.92M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.24M |
| Total Assets | Q1 2026 · Mar 31, 2025 | $7.75M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.97 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.28 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.97 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.1M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.08M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.78M |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $1.94M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$2.82M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$2.95M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$2.88M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$3.03M |